Osteoblasts mineralization and collagen matrix are conserved upon specific Col1a2 silencing

[1]  Brendan H. Lee,et al.  Osteogenesis imperfecta: advancements in genetics and treatment. , 2019, Current opinion in pediatrics.

[2]  Yuanyu Huang,et al.  RNAi therapeutic and its innovative biotechnological evolution. , 2019, Biotechnology advances.

[3]  M. Nesbit,et al.  Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Corneal Epithelium Using a Modified Cell-Penetrating Peptide , 2019, Molecular therapy. Nucleic acids.

[4]  C. Chow,et al.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes , 2019, The FEBS journal.

[5]  J. Schwartz,et al.  Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification , 2019, Matrix biology : journal of the International Society for Matrix Biology.

[6]  G. Christofori,et al.  Tenascin-C increases lung metastasis by impacting blood vessel invasions. , 2019, Matrix biology : journal of the International Society for Matrix Biology.

[7]  P. Cortelli,et al.  Allele-specific silencing as treatment for gene duplication disorders: proof-of-principle in autosomal dominant leukodystrophy. , 2019, Brain : a journal of neurology.

[8]  M. Tammi,et al.  Effects of mutations in the post-translational modification sites on the trafficking of hyaluronan synthase 2 (HAS2). , 2019, Matrix biology : journal of the International Society for Matrix Biology.

[9]  M. Biggiogera,et al.  Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate , 2019, Disease Models & Mechanisms.

[10]  Nikhil A. Jain,et al.  Allele-specific silencing ameliorates restrictive cardiomyopathy due to a human myosin regulatory light chain mutation , 2019, bioRxiv.

[11]  S. Solomon,et al.  Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis , 2018, The New England journal of medicine.

[12]  M. Biggiogera,et al.  4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[13]  D. Schuppan,et al.  Liver fibrosis: Direct antifibrotic agents and targeted therapies. , 2018, Matrix biology : journal of the International Society for Matrix Biology.

[14]  R. Morello.  Osteogenesis imperfecta and therapeutics. , 2018, Matrix biology : journal of the International Society for Matrix Biology.

[15]  M. Karsdal,et al.  Inducible knockdown of procollagen I protects mice from liver fibrosis and leads to dysregulated matrix genes and attenuated inflammation. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[16]  Marian F Young,et al.  Skeletal biology: Where matrix meets mineral. , 2016, Matrix biology : journal of the International Society for Matrix Biology.

[17]  A. Forlino,et al.  Osteogenesis imperfecta , 2016, The Lancet.

[18]  S. Bressler,et al.  Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo. , 2016, Matrix biology : journal of the International Society for Matrix Biology.

[19]  J. Yoon,et al.  Evaluation of bone regeneration with biphasic calcium phosphate substitute implanted with bone morphogenetic protein 2 and mesenchymal stem cells in a rabbit calvarial defect model. , 2015, Oral surgery, oral medicine, oral pathology and oral radiology.

[20]  A. Forlino,et al.  Treatment options for osteogenesis imperfecta , 2015 .

[21]  P. Layrolle,et al.  Bone tissue formation with human mesenchymal stem cells and biphasic calcium phosphate ceramics: the local implication of osteoclasts and macrophages. , 2014, Biomaterials.

[22]  P. Layrolle,et al.  Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate , 2013, Stem Cell Research & Therapy.

[23]  R. Gioia,et al.  Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta , 2013, European Journal of Human Genetics.

[24]  C. Rubin,et al.  Allele Dependent Silencing of Collagen Type I Using Small Interfering RNAs Targeting 3'UTR Indels - a Novel Therapeutic Approach in Osteogenesis Imperfecta , 2013, International journal of medical sciences.

[25]  M. Kassem,et al.  Mouse Embryonic Fibroblasts (MEF) Exhibit a Similar but not Identical Phenotype to Bone Marrow Stromal Stem Cells (BMSC) , 2012, Stem Cell Reviews and Reports.

[26]  Sejin Han,et al.  Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion. , 2010, Cancer research.

[27]  Haitao Li,et al.  Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine. , 2010, The American journal of pathology.

[28]  Mauro Ferrari,et al.  Sustained small interfering RNA delivery by mesoporous silicon particles. , 2010, Cancer research.

[29]  D. Scherman,et al.  Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models , 2010, Cancer Gene Therapy.

[30]  C. Rubin,et al.  Allele dependent silencing of COL1A2 using small interfering RNAs , 2008, International journal of medical sciences.

[31]  P. Byers,et al.  Defective C-propeptides of the Proα2(I) Chain of Type I Procollagen Impede Molecular Assembly and Result in Osteogenesis Imperfecta* , 2008, Journal of Biological Chemistry.

[32]  F. Glorieux,et al.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans , 2007, Human mutation.

[33]  D. Scherman,et al.  Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis. , 2006, Arthritis and rheumatism.

[34]  A. Aigner.  Delivery Systems for the Direct Application of siRNAs to Induce RNA Interference (RNAi) In Vivo , 2006, Journal of biomedicine & biotechnology.

[35]  T. Ochiya,et al.  Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Aigner,et al.  RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo , 2005, Gene Therapy.

[37]  P. Byers,et al.  Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. , 2004, American journal of human genetics.

[38]  I. Toudjarska,et al.  Delivery of a hammerhead ribozyme specifically downregulates mutant type I collagen mRNA in a murine model of osteogenesis imperfecta. , 2001, Antisense & nucleic acid drug development.

[39]  P. Dawson,et al.  Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts. , 2000, Nucleic acids research.

[40]  A. Forlino,et al.  Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects. , 1997, Nucleic acids research.

[41]  M. Willing,et al.  Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains. , 1996, American journal of human genetics.

[42]  D. Prockop,et al.  Partial rescue of a lethal phenotype of fragile bones in transgenic mice with a chimeric antisense gene directed against a mutated collagen gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M T Davisson,et al.  Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[44]  I. Damjanov,et al.  Synthesis of type I homotrimer collagen molecules by cultured human lung adenocarcinoma cells. , 1988, The American journal of pathology.

[45]  R. Hoover,et al.  Collagen polymorphism in cultured rat kidney mesangial cells. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[46]  M. Gould,et al.  Advantages of picrate fixation for staining polypeptides in polyacrylamide gels. , 1986, Analytical biochemistry.

[47]  R. Page,et al.  Action of mammalian collagenases on type I trimer collagen. , 1984, Collagen and related research.

[48]  H. Ehrlich,et al.  Evidence for type V and I trimer collagens in Dupuytren's Contracture palmar fascia. , 1982, Biochemical medicine.

[49]  R. Page,et al.  Characterization of collagens of diseased human gingiva. , 1980, Biochemistry.

[50]  M Rojkind,et al.  Collagen types in normal and cirrhotic liver. , 1979, Gastroenterology.

[51]  J. Uitto.  Collagen polymorphism: isolation and partial characterization of alpha 1(I)-trimer molecules in normal human skin. , 1979, Archives of biochemistry and biophysics.

[52]  S. Jimenez,et al.  Identification of collagen α1(I) trimer in embryonic chick tendons and calvaria , 1977 .

[53]  L. Moro,et al.  Identification of collagen alpha1(I) trimer and normal type I collagen in a polyoma virus-induced mouse tumor. , 1977, Archives of biochemistry and biophysics.

[54]  A. Forlino,et al.  Steady-State and Pulse-Chase Analyses of Fibrillar Collagen. , 2019, Methods in molecular biology.

[55]  L. Matos,et al.  RNA Therapeutics: How Far Have We Gone? , 2019, Advances in experimental medicine and biology.

[56]  ScienceDirect.  Matrix biology : journal of the International Society for Matrix Biology. , 1994 .

[57]  S. Yamagata,et al.  FBJ virus-induced osteosarcoma contains type I, type I trimer, type III as well as type V collagens. , 1984, Journal of biochemistry.

[58]  R. Jaenisch,et al.  Embryonic lethal mutation in mice induced by retrovirus insertion into the alpha 1(I) collagen gene. , 1983, Nature.

[59]  R. Jaenisch,et al.  Embryonic lethal mutation in mice induced by retrovirus insertion into the α1(I) collagen gene , 1983, Nature.

[60]  S. Jimenez,et al.  Identification of collagen alpha1(I) trimer in embryonic chick tendons and calvaria. , 1977, Biochemical and biophysical research communications.